Quantcast
Last updated on April 16, 2014 at 13:01 EDT

Latest National Comprehensive Cancer Network Stories

2012-03-19 11:58:15

People are living longer with and after a cancer diagnosis, making survivorship clinics and programs–as well as official guidelines and practices governing the care of survivors–an important emerging component of modern cancer care. Many institutions are looking to gather these resources into an easily understandable plan for their survivors. "Cancer survivors face a lot of unique and very specific challenges," says Crystal S. Denlinger, M.D., a medical oncologist at Fox Chase...

2012-03-16 14:20:22

Calls For Inclusion of Low Dose CT Screening For Those At High Risk For Lung Cancer WASHINGTON, March 16, 2012 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) said that the new anti-tobacco campaign just launched by the Centers for Disease Control and Prevention (CDC) is an important revitalization of the efforts to prevent young people from smoking and encourage all who do smoke to quit. LCA President and CEO, Laurie Fenton Ambrose said, "this is among our top...

2012-03-01 09:30:00

SAN DIEGO, March 1, 2012 /PRNewswire/ -- RainTree Oncology Services today announced its newest member, Tennessee Cancer Specialists. Based in Knoxville, Tennessee Cancer Specialists is a leader in community-based comprehensive cancer care. The practice addition expands RainTree Oncology's network to 504 physicians. "We are very excited about our new partnership with RainTree Oncology," said Dr. Mitchell Martin, president of Tennessee Cancer Specialists. "We recognize that oral...

2012-02-02 09:30:00

SAN DIEGO, Feb. 2, 2012 /PRNewswire/ -- RainTree Oncology Services today announced that Dayton Physicians Network and The Zangmeister Center, based in Columbus, Ohio, leaders in technically advanced, high quality community-based medical and cancer care, have joined the RainTree Oncology membership to obtain access to advanced oral oncologic drug acquisition and management services. With these additions, RainTree Oncology's physician membership has expanded to 491 physicians from leading...

2012-01-24 12:05:00

PITTSBURGH, Jan. 24, 2012 /PRNewswire/ -- Precision Therapeutics, Inc. has recently expanded their BioSpeciFx® product to include 21 clinically-relevant biomarkers to help physicians with their treatment decisions. This enhances Precision's approach to personalizing cancer care by offering additional molecular markers, including the recently FDA-approved ALK-FISH test. By utilizing BioSpeciFx® results in combination with Precision Therapeutics' ChemoFx® in vitro drug response...

2012-01-20 07:00:00

REDWOOD CITY, Calif., Jan. 20, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of the first clinical decision making study of the Oncotype DX® colon cancer test that shows that Recurrence Score® (RS) result has a significant impact on treatment recommendations for stage II colon cancer patients. The data, to be presented at the 2012 Gastrointestinal (GI) Cancers Symposium, demonstrate that knowledge of a patient's Recurrence Score changes...

2012-01-16 07:00:00

BREA, Calif., Jan. 16, 2012 /PRNewswire/ -- New Century Health announced today that its board of directors has appointed Atul Dhir, M.D., Ph.D., chief executive officer. Dr. Dhir will spearhead the national expansion of New Century Health's specialty care management services focused on oncology and cardiology. Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care that invested in New Century Health last year, recruited...

2012-01-09 07:00:00

REDWOOD CITY, Calif., Jan. 9, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it has started a large clinical validation study of its prostate cancer test. The study, being performed in collaboration with leading prostate cancer researchers at the University of California, San Francisco (UCSF), is designed to determine if a multi-gene test can help distinguish aggressive disease requiring surgery from less aggressive disease that may undergo active...

2012-01-01 08:00:00

The Oncology Institute of Hope and Innovation, the leader in providing comprehensive cancer treatment, is celebrating its 18 month anniversary in Anaheim under the leadership of Dr. Daniel Jae Kim. Anaheim, CA (PRWEB) January 01, 2012 The Oncology Institute of Hope and Innovation, the leader in providing comprehensive cancer treatment, is celebrating its 18 month anniversary in Anaheim under the leadership of Dr. Daniel Jae Kim. Dr. Kim, a leader in cancer treatment with accolades in...

2011-12-05 17:56:00

IRVINE, Calif., Dec. 5, 2011 /PRNewswire/ -- OvaGene Oncology Inc., a molecular diagnostics company specializing in the development and commercialization of personalized gene-based diagnostics for gynecologic cancer, announced today that it has completed a major Licensing and Collaboration Agreement with The Moffitt Cancer Center, the only National Cancer Institute (NCI) Comprehensive Cancer Center in Florida. The agreement provides OvaGene with exclusive worldwide rights to develop and...